US Patent 7265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
The current invention relates to a series of rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms, specifically, the 3,4-cyclo-rifamycin derivatives having an oxime group at the C-11 position.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes US Patent 7265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
Infobox
Patent Number
0726510700
Patent Number
726510700
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072651070
Date of Patent
September 4, 2007
0Patent Application Number
110761730
Date Filed
March 9, 2005
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072651070
Date of Patent
September 4, 2007
0Patent Application Number
110761730
Date Filed
March 9, 2005
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
Infobox
Is a
Patent jurisdiction
Patent number
07265107
Date of patent
September 4, 2007
Patent application number
11076173
Date Filed
March 9, 2005
Patent primary examiner
Find more entities like US Patent 7265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
